Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Am Acad Dermatol. 2018 Apr 14;80(5):1199–1213. doi: 10.1016/j.jaad.2018.03.056

Figure 1.

Figure 1

Persistent chemotherapy-induced alopecia (pCIA). A. Diffuse alopecia in a breast cancer survivor, 2 years after taxane based chemotherapy completion. B. pCIA in a breast cancer survivor, 1.6 years after taxane based chemotherapy completion with similar pattern of androgenetic alopecia, predominant hair thinning on the crown area. C. Trichoscopy of patient in figure B, featuring hair thinning, miniaturized hairs, and yellow dots. D. Histology section featuring mild perifollicular inflammation and fibrosis, (hematoxylin-eosin stain).